Dr. Peter Adamson is Chair of the Children’s Oncology Group (COG), a National Cancer Institute (NCI) supported international consortium of more than 220 childhood centers that conducts clinical-translational research, including large-scale clinical trials, in children with cancer. He is Professor of Pediatrics and Pharmacology at the Perelman School of Medicine of the University of Pennsylvania and he holds the Alan R. Cohen Endowed Chair in Pediatrics at The Children’s Hospital of Philadelphia (CHOP). Dr. Adamson is Board Certified in Pediatric Hematology/Oncology and in Clinical Pharmacology. He currently serves on the National Cancer Advisory Board (NCAB) and is an internationally recognized leader in pediatric cancer drug development. He has also been has been appointed a member of the Blue Ribbon Panel of cancer leaders that will help direct the goals of Vice President Joe Biden’s National Cancer Moonshot Initiative.